Metabolic regulation of gene expression through histone acylations

Nature Reviews Molecular Cell Biology

Volumn 18, Issue 2, 2017, Pages 90-101

  Sabari, Benjamin R ^a   Zhang, Di ^b   Allis, C David ^a   Zhao, Yingming ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACYL COENZYME A; HISTONE; LYSINE; SHORT CHAIN FATTY ACID; ACETYL COENZYME A; VOLATILE FATTY ACID;

ACYLATION; CHEMICAL STRUCTURE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HISTONE ACYLATION; HISTONE MODIFICATION; HUMAN; METABOLIC REGULATION; METABOLIC STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; SPERMATOGENESIS; TISSUE INJURY; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PHYSIOLOGICAL STRESS; PROTEIN PROCESSING;

ACETYL COENZYME A; ACYL COENZYME A; ACYLATION; ANIMALS; FATTY ACIDS, VOLATILE; GENE EXPRESSION REGULATION; HISTONES; HUMANS; LYSINE; MALE; PROTEIN DOMAINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPERMATOGENESIS; STRESS, PHYSIOLOGICAL;

EID: 85001574636     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm.2016.140     Document Type: Review

References (106)

1. Dawson, M. A. & Kouzarides, T. Cancer epigenetics: from mechanism to therapy. Cell 150, 12-27 (2012).
2. Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27-47 (2016).
3. Ronan, J. L., Wu, W. & Crabtree, G. R. From neural development to cognition: unexpected roles for chromatin. Nat. Rev. Genet. 14, 347-359 (2013).
4. Lewis, P. W. et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340, 857-861 (2013).
5. Lu, C. et al. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape. Science 352, 844-849 (2016).
6. Huang, H., Sabari, B. R., Garcia, B. A., Allis, C. D. & Zhao, Y. SnapShot: histone modifications. Cell 159, 458-458.e1 (2014).
7. Chen, Y. et al. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteomics 6, 812-819 (2007).
8. Dai, L. Z. et al. Lysine 2-hydroxyisobutyrylation is a widely distributed active histone mark. Nat. Chem. Biol. 10, 365-370 (2014).
9. Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 11, 100-107 (2012).
10. Tan, M. J. et al. Lysine glutarylation is a protein posttranslational modification regulated by SIRT5. Cell Metab. 19, 605-617 (2014).
11. Tan, M. J. et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146, 1015-1027 (2011).
12. Xie, Z. et al. Metabolic regulation of gene expression by histone lysine β-hydroxybutyrylation. Mol. Cell 62, 194-206 (2016).
13. Choudhary, C., Weinert, B. T., Nishida, Y., Verdin, E. & Mann, M. The growing landscape of lysine acetylation links metabolism and cell signalling. Nat. Rev. Mol. Cell Biol. 15, 536-550 (2014).
14. Phillips, D. M. The presence of acetyl groups of histones. Biochem. J. 87, 258-263 (1963).
15. Allfrey, V. G., Faulkner, R. & Mirsky, A. E. Acetylation and methylation of histones and their possible role in regulation of RNA synthesis. Proc. Natl Acad. Sci. USA 51, 786-794 (1964).
16. Fan, J., Krautkramer, K. A., Feldman, J. L. & Denu, J. M. Metabolic regulation of histone post-translational modifications. ACS Chem. Biol. 10, 95-108 (2015).
17. Etchegaray, J. P. & Mostoslavsky, R. Interplay between metabolism and epigenetics: a nuclear adaptation to environmental changes. Mol. Cell 62, 695-711 (2016).
18. Su, X., Wellen, K. E. & Rabinowitz, J. D. Metabolic control of methylation and acetylation. Curr. Opin. Chem. Biol. 30, 52-60 (2016).
19. Zhang, Y., Fonslow, B. R., Shan, B., Baek, M. C. & Yates, J. R. III. Protein analysis by shotgun/bottom-up proteomics. Chem. Rev. 113, 2343-2394 (2013).
20. Olsen, J. V. & Mann, M. Status of large-scale analysis of post-translational modifications by mass spectrometry. Mol. Cell. Proteomics 12, 3444-3452 (2013).
21. Kim, S. C. et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23, 607-618 (2006).
22. Peng, C. et al. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol. Cell. Proteomics 10, M111.012658 (2011).
23. Tsur, D., Tanner, S., Zandi, E., Bafna, V. & Pevzner, P. A. Identification of post-translational modifications by blind search of mass spectra. Nat. Biotechnol. 23, 1562-1567 (2005).
24. Hansen, B. T., Davey, S. W., Ham, A. J. & Liebler, D. C. P-Mod: an algorithm and software to map modifications to peptide sequences using tandem MS data. J. Proteome Res. 4, 358-368 (2005).
25. Chen, Y., Chen, W., Cobb, M. H. & Zhao, Y. PTMap-a sequence alignment software for unrestricted, accurate, and full-spectrum identification of post-translational modification sites. Proc. Natl Acad. Sci. USA 106, 761-766 (2009).
26. Chick, J. M. et al. A mass-tolerant database search identifies a large proportion of unassigned spectra in shotgun proteomics as modified peptides. Nat. Biotechnol. 33, 743-749 (2015).
27. Moellering, R. E. & Cravatt, B. F. Functional lysine modification by an intrinsically reactive primary glycolytic metabolite. Science 341, 549-553 (2013).
28. Wagner, G. R. & Payne, R. M. Widespread and enzyme-independent Nϵ-acetylation and Nϵ-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J. Biol. Chem. 288, 29036-29045 (2013).
29. Weinert, B. T., Moustafa, T., Iesmantavicius, V., Zechner, R. & Choudhary, C. Analysis of acetylation stoichiometry suggests that SIRT3 repairs nonenzymatic acetylation lesions. EMBO J. 34, 2620-2632 (2015).
30. Weinert, B. T. et al. Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae. Mol. Syst. Biol. 10, 716 (2014).
31. Lee, K. K. & Workman, J. L. Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell Biol. 8, 284-295 (2007).
32. Roth, S. Y., Denu, J. M. & Allis, C. D. Histone acetyltransferases. Annu. Rev. Biochem. 70, 81-120 (2001).
33. Bannister, A. J. & Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643 (1996).
34. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H. & Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959 (1996).
35. Cheng, Z. et al. Molecular characterization of propionyllysines in non-histone proteins. Mol. Cell. Proteomics 8, 45-52 (2009).
36. Sabari, B. R. et al. Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation. Mol. Cell 58, 203-215 (2015).
37. Kaczmarska, Z. et al. Structure of p300 in complex with acyl-CoA variants. Nat. Chem. Biol. http://dx.doi.org/10.1038/nchembio.2217 (2016).
38. Hu, A., Britton, L. M. & Garcia, B. A. Investigating the specificity of histone acetyltransferase activity for producing rare modifications on histones using mass spectrometry. The 62nd Annu. Am. Soc. Mass Spectrom. Conference Mass Spectrom. Allied Top., Baltimore, MD. https://www.abstracts.asms.org/pages/dashboard.html#/conference/252/toc/252/details (2014).
39. Yu-Ying, Y., Markus, G. & Howard, H. C. Identification of lysine acetyltransferase p300 substrates using 4-pentynoyl-coenzyme A and bioorthogonal proteomics. Bioorg. Med. Chem. Lett. 21, 4976-4979 (2011).
40. Berndsen, C. E., Albaugh, B. N., Tan, S. & Denu, J. M. Catalytic mechanism of a MYST family histone acetyltransferase. Biochemistry 46, 623-629 (2007).
41. Leemhuis, H., Packman, L. C., Nightingale, K. P. & Hollfelder, F. The human histone acetyltransferase P/CAF is a promiscuous histone propionyltransferase. Chembiochem 9, 499-503 (2008).
42. Ringel, A. E. & Wolberger, C. Structural basis for acyl group discrimination by human Gcn5L2. Acta Crystallogr. D Struct. Biol. 72, 841-848 (2016).
43. de Ruijter, A. J., van Gennip, A. H., Caron, H. N., Kemp, S. & van Kuilenburg, A. B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737-749 (2003).
44. Jing, H. & Lin, H. Sirtuins in epigenetic regulation. Chem. Rev. 115, 2350-2375 (2015).
45. Smith, B. C. & Denu, J. M. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases. J. Biol. Chem. 282, 37256-37265 (2007).
46. Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800 (2000).
47. Du, J. T. et al. Sirt5 Is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809 (2011).
48. Park, J. et al. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol. Cell 50, 919-930 (2013).
49. Feldman, J. L., Baeza, J. & Denu, J. M. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J. Biol. Chem. 288, 31350-31356 (2013).
50. Barber, M. F. et al. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487, 114-118 (2012).
51. Li, L. et al. SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability. Nat. Commun. 7, 12235 (2016).
52. Bao, X. C. et al. Identification of 'erasers' for lysine crotonylated histone marks using a chemical proteomics approach. eLife 3, e02999 (2014).
53. Scholz, C. et al. Acetylation site specificities of lysine deacetylase inhibitors in human cells. Nat. Biotechnol. 33, 415-423 (2015).
54. Chen, Y. et al. Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways. Mol. Cell. Proteomics 11, 1048-1062 (2012).
55. Madsen, A. S. & Olsen, C. A. Profiling of substrates for zinc-dependent lysine deacylase enzymes: HDAC3 exhibits decrotonylase activity in vitro. Angew. Chem. Int. Ed. 51, 9083-9087 (2012).
56. Vollmuth, F. & Geyer, M. Interaction of propionylated and butyrylated histone H3 lysine marks with Brd4 bromodomains. Angew. Chem. Int. Ed. 49, 6768-6772 (2010).
57. Flynn, E. M. et al. A subset of human bromodomains recognizes butyryllysine and crotonyllysine histone peptide modifications. Structure 23, 1801-1814 (2015).
58. Moriniere, J. et al. Cooperative binding of two acetylation marks on a histone tail by a single bromodomain. Nature 461, 664-668 (2009).
59. Goudarzi, A. et al. Dynamic competing histone H4 K5K8 acetylation and butyrylation are hallmarks of highly active gene promoters. Mol. Cell 62, 169-180 (2016).
60. Li, Y. Y. et al. AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79 methylation. Cell 159, 558-571 (2014).
61. Shanle, E. K. et al. Association of Taf14 with acetylated histone H3 directs gene transcription and the DNA damage response. Genes Dev. 29, 1795-1800 (2015).
62. Schulze, J. M., Wang, A. Y. & Kobor, M. S. YEATS domain proteins: a diverse family with many links to chromatin modification and transcription. Biochem. Cell Biol. 87, 65-75 (2009).
63. Li, Y. et al. Molecular coupling of histone crotonylation and active transcription by AF9 YEATS domain. Mol. Cell 62, 181-193 (2016).
64. Zhao, D. et al. YEATS2 is a selective histone crotonylation reader. Cell Res. 26, 629-632 (2016).
65. Andrews, F. H. et al. The Taf14 YEATS domain is a reader of histone crotonylation. Nat. Chem. Biol. 12, 396-398 (2016).
66. Zhang, Q. et al. Structural Insights into histone crotonyl-lysine recognition by the AF9 YEATS domain. Structure 24,1606-1612 (2016).
67. Wysocka, J. et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442, 86-90 (2006).
68. Li, H. T. et al. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 442, 91-95 (2006).
69. Shi, X. B. et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442, 96-99 (2006).
70. Pena, P. V. et al. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 442, 100-103 (2006).
71. Lange, M. et al. Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex. Genes Dev. 22, 2370-2384 (2008).
72. Qiu, Y. et al. Combinatorial readout of unmodified H3R2 and acetylated H3K14 by the tandem PHD finger of MOZ reveals a regulatory mechanism for HOXA9 transcription. Genes Dev. 26, 1376-1391 (2012).
73. Dreveny, I. et al. The double PHD finger domain of MOZ/MYST3 induces α-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification. Nucleic Acids Res. 42, 822-835 (2014).
74. Zeng, L. et al. Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature 466, 258-262 (2010).
75. Ali, M. et al. Tandem PHD fingers of MORF/MOZ acetyltransferases display selectivity for acetylate histone H3 and are required for the association with chromatin. J. Mol. Biol. 424, 328-338 (2012).
76. Xiong, X. et al. Selective recognition of histone crotonylation by double PHD fingers of MOZ and DPF2. Nat. Chem. Biol. http://dx.doi.org/10.1038/nchembio.2218 (2016).
77. Wellen, K. E. et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076-1080 (2009).
78. Bhanu, N. A.-S., L. & Garcia, B. A. Quantification of lysine crotonylation during in vitro human myogenic differentiation. The 61st Annu. Am. Soc. Mass Spectrom. Conference Mass Spectrom. Allied Top. https://www.abstracts.asms.org/pages/dashboard.html#/conference/253/toc/253/details (2013).
79. Tweedie-Cullen, R. Y. et al. Identification of combinatorial patterns of post-translational modifications on individual histones in the mouse brain. PLoS ONE 7, e36980 (2012).
80. Comerford, S. A. et al. Acetate dependence of tumors. Cell 159, 1591-1602 (2014).
81. Mashimo, T. et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159, 1603-1614 (2014).
82. Hallows, W. C., Lee, S. & Denu, J. M. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl Acad. Sci. USA 103, 10230-10235 (2006).
83. Wellen, K. E. & Thompson, C. B. A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 13, 270-276 (2012).
84. Cahill, G. F. Jr. Fuel metabolism in starvation. Annu. Rev. Nutr. 26, 1-22 (2006).
85. Robinson, A. M. & Williamson, D. H. Physiological roles of ketone-bodies as substrates and signals in mammalian-tissues. Physiol. Rev. 60, 143-187 (1980).
86. Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20, 306-319 (2014).
87. Ruiz-Andres, O. et al. Histone lysine crotonylation during acute kidney injury in mice. Dis. Model. Mech. 9, 633-645 (2016).
88. Gaucher, J. et al. Bromodomain-dependent stage-specific male genome programming by Brdt. EMBO J. 31, 3809-3820 (2012).
89. An, W., Palhan, V. B., Karymov, M. A., Leuba, S. H. & Roeder, R. G. Selective requirements for histone H3 and H4 N termini in p300-dependent transcriptional activation from chromatin. Mol. Cell 9, 811-821 (2002).
90. Kundu, T. K. et al. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol. Cell 6, 551-561 (2000).
91. Hilton, I. B. et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 33, 510-517 (2015).
92. Smale, S. T., Tarakhovsky, A. & Natoli, G. Chromatin contributions to the regulation of innate immunity. Annu. Rev. Immunol. 32, 489-511 (2014).
93. Sin, H. S. et al. RNF8 regulates active epigenetic modifications and escape gene activation from inactive sex chromosomes in post-meiotic spermatids. Genes Dev. 26, 2737-2748 (2012).
94. Montellier, E., Rousseaux, S., Zhao, Y. & Khochbin, S. Histone crotonylation specifically marks the haploid male germ cell gene expression program: post-meiotic male-specific gene expression. Bioessays 34, 187-193 (2012).
95. Rousseaux, S. & Khochbin, S. Histone acylation beyond acetylation: terra incognita in chromatin biology. Cell J. 17, 1-6 (2015).
96. McNally, M. A. & Hartman, A. L. Ketone bodies in epilepsy. J. Neurochem. 121, 28-35 (2012).
97. Kashiwaya, Y. et al. D-β-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc. Natl Acad. Sci. USA 97, 5440-5444 (2000).
98. Lim, S. et al. D-β-hydroxybutyrate is protective in mouse models of Huntington's disease. PLoS ONE 6, e24620 (2011).
99. Shimazu, T. et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339, 211-214 (2013).
100. Boukouris, A. E., Zervopoulos, S. D. & Michelakis, E. D. Metabolic enzymes moonlighting in the nucleus: metabolic regulation of gene transcription. Trends Biochem. Sci. 41, 712-730 (2016).
101. Yang, X. J. & Seto, E. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat. Rev. Mol. Cell Biol. 9, 206-218 (2008).
102. Legube, G. & Trouche, D. Regulating histone acetyltransferases and deacetylases. EMBO Rep. 4, 944-947 (2003).
103. Tsuchiya, Y., Pham, U. & Gout, I. Methods for measuring CoA and CoA derivatives in biological samples. Biochem. Soc. Trans. 42, 1107-1111 (2014).
104. Liu, X. et al. High-resolution metabolomics with acyl-CoA profiling reveals widespread remodeling in response to diet. Mol. Cell. Proteomics 14, 1489-1500 (2015).
105. Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Backhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332-1345 (2016).
106. Lin, H., Su, X. & He, B. Protein lysine acylation and cysteine succination by intermediates of energy metabolism. ACS Chem. Biol. 7, 947-960 (2012).